These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2014242)

  • 1. Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity.
    Kräusslich HG
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3213-7. PubMed ID: 2014242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific inhibitor of human immunodeficiency virus proteinase prevents the cytotoxic effects of a single-chain proteinase dimer and restores particle formation.
    Kräusslich HG
    J Virol; 1992 Jan; 66(1):567-72. PubMed ID: 1727499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleavage of human immunodeficiency virus type 1 proteinase from the N-terminally adjacent p6* protein is essential for efficient Gag polyprotein processing and viral infectivity.
    Tessmer U; Kräusslich HG
    J Virol; 1998 Apr; 72(4):3459-63. PubMed ID: 9525682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity.
    Rosé JR; Babé LM; Craik CS
    J Virol; 1995 May; 69(5):2751-8. PubMed ID: 7535864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity.
    Konvalinka J; Litterst MA; Welker R; Kottler H; Rippmann F; Heuser AM; Kräusslich HG
    J Virol; 1995 Nov; 69(11):7180-6. PubMed ID: 7474139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria.
    Luban J; Lee C; Goff SP
    J Virol; 1993 Jun; 67(6):3630-4. PubMed ID: 8497070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic mutational analysis of the active-site threonine of HIV-1 proteinase: rethinking the "fireman's grip" hypothesis.
    Strisovsky K; Tessmer U; Langner J; Konvalinka J; Kräusslich HG
    Protein Sci; 2000 Sep; 9(9):1631-41. PubMed ID: 11045610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of sequences upstream of the proteinase improves the proteolytic processing of human immunodeficiency virus type 1.
    Partin K; Zybarth G; Ehrlich L; DeCrombrugghe M; Wimmer E; Carter C
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4776-80. PubMed ID: 1647017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation.
    Babé LM; Rosé J; Craik CS
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10069-73. PubMed ID: 7479728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of the protease of human endogenous retrovirus, K10: can it complement HIV-1 protease?
    Towler EM; Gulnik SV; Bhat TN; Xie D; Gustschina E; Sumpter TR; Robertson N; Jones C; Sauter M; Mueller-Lantzsch N; Debouck C; Erickson JW
    Biochemistry; 1998 Dec; 37(49):17137-44. PubMed ID: 9860826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic processing mechanisms of a miniprecursor of the aspartic protease of human immunodeficiency virus type 1.
    Co E; Koelsch G; Lin Y; Ido E; Hartsuck JA; Tang J
    Biochemistry; 1994 Feb; 33(5):1248-54. PubMed ID: 8110758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
    Park J; Morrow CD
    Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative properties of feline immunodeficiency virus (FIV) and human immunodeficiency virus type 1 (HIV-1) proteinases prepared by total chemical synthesis.
    Schnölzer M; Rackwitz HR; Gustchina A; Laco GS; Wlodawer A; Elder JH; Kent SB
    Virology; 1996 Oct; 224(1):268-75. PubMed ID: 8862421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-ray analysis of HIV-1 proteinase at 2.7 A resolution confirms structural homology among retroviral enzymes.
    Lapatto R; Blundell T; Hemmings A; Overington J; Wilderspin A; Wood S; Merson JR; Whittle PJ; Danley DE; Geoghegan KF
    Nature; 1989 Nov; 342(6247):299-302. PubMed ID: 2682266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.
    Lin YC; Brik A; de Parseval A; Tam K; Torbett BE; Wong CH; Elder JH
    J Virol; 2006 Aug; 80(16):7832-43. PubMed ID: 16873240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an active single polypeptide form of the human immunodeficiency virus type 1 protease.
    DiIanni CL; Davis LJ; Holloway MK; Herber WK; Darke PL; Kohl NE; Dixon RA
    J Biol Chem; 1990 Oct; 265(28):17348-54. PubMed ID: 2211628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maturation of human immunodeficiency virus particles assembled from the gag precursor protein requires in situ processing by gag-pol protease.
    Ross EK; Fuerst TR; Orenstein JM; O'Neill T; Martin MA; Venkatesan S
    AIDS Res Hum Retroviruses; 1991 May; 7(5):475-83. PubMed ID: 1873082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1.
    Paulus C; Ludwig C; Wagner R
    Virology; 2004 Dec; 330(1):271-83. PubMed ID: 15527852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of substrates and inhibitors with a family of tethered HIV-1 and HIV-2 homo- and heterodimeric proteinases.
    Griffiths JT; Tomchak LA; Mills JS; Graves MC; Cook ND; Dunn BM; Kay J
    J Biol Chem; 1994 Feb; 269(7):4787-93. PubMed ID: 8106448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
    Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.